Search bioRxiv⌕ Search

Biology subjects

Skerra, J.

Publications and source records attributed to Skerra, J..

2 recordsLinked to original sources

Nipah virus Malaysia and Bangladesh strain-induced pathogenesis in mice lacking type I interferon receptor signaling

Nipah virus (NiV) is a zoonotic highly pathogenic Paramyxovirus inducing lethal outbreaks of encephalitis and severe acute respiratory syndrome (SARS) with an average case-fatality rate of 75%. Two viral strains, NiV-Malaysia (NiV-Mal) and NiV-Bangladesh (NiV-Ban), associated to distinct geographical distribution, route of transmission, symptoms and lethality have been described. Due to the permanent threat of these emerging infections and the lack of approved therapeutics, it is crucial to improve our understanding regarding NiV-associated pathogenesis. Mice represent a small and accessible animal model, provided with numerous biological tools for the functional assessment of different genes related to antiviral response. Here, we analyze the susceptibility of mice deficient for type I interferon receptor (IFNAR KO) to infection with either NiV-Mal or NiV-Ban through intraperitoneal or intranasal routes. Our results show that IFNAR KO mice are susceptible to NiV-Ban infection via intraperitoneal route, although to a lesser extent than NiV-Mal, and develop encephalitis and pulmonary syndrome with viral propagation to different organs and lethal outcome in 60% of infected animals. In addition, intranasal administration of both viral strains led to a subclinical infection with viral replication in brain and lungs and production of virus-specific neutralizing antibodies. These results indicate IFNAR KO mice as a small animal model permitting comparative studies of the immunopathogenesis perpetrated by both NiV-Mal and NiV-Ban infections. Author summaryAvailability of small animal models represents a major issue to characterize virus-associated pathogenesis to further implement therapeutic strategies. Previous studies performed with NiV-Mal and NiV-Ban strains in wild-type (WT) mice did not indicate signs of NiV disease. However, when challenged with NiV-Mal, IFNAR KO mice suffered fatal outcomes, thus providing useful information on viral immunopathogenesis. Surprisingly, while being the more frequently re-emerging virus strain, no infection studies with NiV-Ban have been performed in IFNAR KO mice so far. Here, we sought comparing pathogenesis after NiV-Mal- and NiV-Ban-infection following IP and IN inoculations in IFNAR KO mice. Indeed, our results highlighted that contrary to fatal IP challenge, IN inoculation lead to a subclinical infection with both NiV strains. Moreover, we determined that NiV-Mal is more pathogenic than NiV-Ban following IP infection. Finally, distinct histopathological manifestations and tropism were associated with each viral strain and specific route of infection. Overall, our study implies that IFNAR KO mice represent a useful animal model to study strain-specific NiV pathophysiology.

microbiology↗

The mycotoxin Beauvericin exhibits immunostimulatory effects on dendritic cells via activating the TLR4 signaling pathway

Beauvericin (BEA), a mycotoxin of the enniatin family produced by various toxigenic fungi, has been attributed multiple biological activities such as anti-cancer, anti-inflammatory, and anti-microbial functions. However, effects of BEA on dendritic cells remain unknown so far. Here, we identified effects of BEA on murine granulocyte-macrophage colony-stimulating factor (GM-CSF)-cultured bone marrow derived dendritic cells (BMDCs) and the underlying molecular mechanisms. BEA potently activates BMDCs as signified by elevated IL-12 and CD86 expression. Multiplex immunoassays performed on myeloid differentiation primary response 88 (MyD88) and toll/interleukin-1 receptor (TIR) domain containing adaptor inducing interferon beta (TRIF) single or double deficient BMDCs indicate that BEA induces inflammatory cytokine and chemokine production in a MyD88/TRIF dependent manner. Furthermore, we found that BEA was not able to induce IL-12 or IFN{beta} production in Toll-like receptor 4 (Tlr4)-deficient BMDCs, whereas induction of these cytokines was not compromised in Tlr3/7/9 deficient BMDCs. This suggests that TLR4 might be the functional target of BEA on BMDCs. Consistently, in luciferase reporter assays BEA stimulation significantly promotes NF-{kappa}B activation in mTLR4/CD14/MD2 overexpressing but not control HEK-293 cells. RNA-sequencing analyses further confirmed that BEA induces transcriptional changes associated with the TLR4 signaling pathway. Together, these results identify TLR4 as a cellular BEA sensor and define BEA as a potent activator of BMDCs, implying that this compound can be exploited as a promising candidate structure for vaccine adjuvants or cancer immunotherapies.

immunology↗